Six treated women had no increase in serum prolactin compared to 2 of the control women. Methergine is a registered trademark of Novartis AGManufactured by: Breastfeeding and Maternal Medication. Support BreastfeedingOnLi ne. Milk secreted during this period should be discarded. Methergine Interactions. Ten women received a single intravenous dose of 0.
Outcome of breastfed infants following post-partum methylergonovine treatment.
Methylergonovine (Methergine) use while Breastfeeding
Caution should be exercised in the presence of sepsis, obliterative vascular disease. Pharmacokinetic studies following an I. What special precautions should I follow? These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. Methergine is available in sterile ampuls of 1 mL, containing 0. Animal reproductive studies have not been conducted with Methergine.
Where should I keep my medicine? Methylergonovine is intended for use after delivery of the infant, and it enters breast milk. Not for subcutaneous or intraarterial injection. Amlodipine; Benazepril: Methylergonovine is contraindicated in those with known ergot alkaloid hypersensitivity because they may develop an allergic reaction or other serious adverse event. Do not exceed recommended dosage limits.